Clinical observation of GEM+NVB regimen in retreatment of 24 Advanced NSCLC treated by TAX+DDP regimen / 肿瘤研究与临床
Cancer Research and Clinic
; (6)2000.
Article
en Zh
| WPRIM
| ID: wpr-542443
Biblioteca responsable:
WPRO
ABSTRACT
Objective To appraise the efficacy,survival rate and toxicity of GEM+NVB regimen in retreatment of 24 Advanced NSCLC treated by TAX+DDP regimen.Methods 24 patients with Advanced NSCLC received chemotherapy of GEM+NVB regimen.We evaluate the efficacy,survival rate and toxicity after two periods.Results Among these 24 patients,there was no complete response.Rates of partial response is 29.2 %,the average survival period is 28 weeks.One year survival rate is 34.3 %.Conclusions GEM+NVB regimen is effective as second-line chemotherapy for the Advanced NSCLC patients that have ever been treaded by TAX+DDP regimen.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Cancer Research and Clinic
Año:
2000
Tipo del documento:
Article